Cargando…
Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with ankylosing spondylitis: A 4-week randomized, open-label study
Autores principales: | Fan, Meida, Cao, Shuangyan, Tu, Liudan, Wei, Qiujing, Yuan, Riwei, Li, Xuefeng, Gu, Jieruo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684936/ https://www.ncbi.nlm.nih.gov/pubmed/31423308 http://dx.doi.org/10.3892/br.2019.1232 |
Ejemplares similares
-
Efficacy and Safety of Loxoprofen Hydrogel Transdermal Patch Versus Loxoprofen Tablet in Chinese Patients with Myalgia: A Double-Blind, Double-Dummy, Parallel-Group, Randomized, Controlled, Non-Inferiority Trial
por: Zhao, Dongbao, et al.
Publicado: (2019) -
Loxoprofen: Drug eruption: case report
Publicado: (2020) -
Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy
por: Ou, Jiayong, et al.
Publicado: (2021) -
Loxoprofen‐induced bullous fixed drug eruption
por: Yamada, Takayuki, et al.
Publicado: (2019) -
Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China
por: Tu, Liudan, et al.
Publicado: (2020)